HOME ABOUT US SERVICES RESEARCH EQUITY DERIVATIVES IPO INTERNET TRADING FTP CONTACT US
  
SENSEX -205.40 -0.81%
25149.85
 
NIFTY -689.81 -0.83%
82500.47
 
Nasdaq -45.13 -0.22%
20585.53
 
Nikkei 225 -76.68 -0.19%
39569.68
 
FTSE 100 -34.60 -0.39%
8941.10
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Gennex Laboratories Ltd.
 
Source DateBoard Meeting DateDetails
20-May-2025 30-May-2025 Audited Results
03-Feb-2025 14-Feb-2025 Quarterly Results
05-Nov-2024 14-Nov-2024 Quarterly Results Inter alia, to consider and approve:- 2. Consider the Limited Review Reports' of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30, 2024; 3. Reconstitution of the Audit Committee of the Company; 4. Reconstitution of the Nomination & Remuneration Committee of the Company; 5. Reconstitution of the Stakeholders Relationship Committee of the Company; 6. Other Business items.
28-Aug-2024 06-Sep-2024 A.G.M.
05-Aug-2024 14-Aug-2024 Quarterly Results
21-May-2024 30-May-2024 Audited Results
01-Feb-2024 14-Feb-2024 Quarterly Results
20-Nov-2023 02-Dec-2023 Preferential Issue of shares Inter alia, is to consider the following matter, in addition to the items intimated earlier: 1. Fundraising by way of preferential issue To discuss, consider and approve a proposal for raising further capital and to create, offer, issue and allot such number of equity shares and/ or equity linked instruments or securities, including share warrants or otherwise through preferential allotment in accordance with the relevant provisions of applicable law or any combination thereof, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and all other applicable laws, as may be considered appropriate, subject to such governmental/ statutory/regulatory and other approvals as may be required including the approval of the shareholders of the Company.
03-Nov-2023 14-Nov-2023 Quarterly Results
29-Aug-2023 06-Sep-2023 A.G.M.
03-Aug-2023 14-Aug-2023 Quarterly Results
23-May-2023 30-May-2023 Audited Results
12-Apr-2023 20-Apr-2023 Inter alia, to consider the following: 1. To Consider and Appoint Mr. Dinesh Kumar Kejriwal as a Company Secretary & Compliance Officer of the Company. 2.To Consider and Approve the appointment of Mr. Arihant Baid act as Managing Director in the Deccan Remedies Limited, which is a Subsidiary of Gennex Laboratories Limited.
07-Feb-2023 14-Feb-2023 Quarterly Results
04-Nov-2022 14-Nov-2022 Quarterly Results
19-Sep-2022 26-Sep-2022 Inter alia, to consider and approve :- 1. To consider and approve the Call Notice; 2. Fixation of Record Date for the First and Final Call Money; 3. Determination of Call Money period; 4. Other Business items
30-Aug-2022 06-Sep-2022 Inter-alia, consider the following matters: 1. To decide regarding the conduct of 37th AGM for the year ended March 31, 2022; 2. To Consider and Appoint Scrutinizer of the 37th Annual General Meeting in case of Finalisation of the Date of AGM; 3. Other Business items.
01-Aug-2022 12-Aug-2022 Quarterly Results
13-Jul-2022 16-Jul-2022 Rights Issue Inter-alia , to consider the following matters: 1. To consider and a pprove the Letter of Offer; 2. Fixation of Record Date for Rights Issue; 3 . Determination of Rights Price, No. of shares to be issued and Ratio; 4 . Other Business items.
21-Jun-2022 24-Jun-2022 Right Issue of Equity Shares Inter-alia, to consider the following matters: 1. To discuss the further steps of the proposed Rights Issue; 2. Other Business items.
Page 1 of 6
Prev || Next
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ADINATH COMMODITIES  :   COMMODITIES SEBI REGISTRATION NUMBERS : INZ000042629 MultiCommodity Exchange Ltd (MCX):Member ID -10140 National Commodity and Derivatives Exchange Ltd (NCDEX):Member ID -00622.
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education | Client Collateral Details | NSDL eVoting | Advisory for investors
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By ●●● Accord Fintech Pvt.Ltd.